The proportion of potential candidates for focal therapy in localized prostate cancer in a real-life cohort and their final pathologic results.

Azoulai, D; Boustany, J; Peyromaure, M; Abou Chakra, M; Duquesne, I; Barry Delongchamps, N

Azoulai, D; Boustany, J; Peyromaure, M; Abou Chakra, M; Duquesne, I; Barry Delongchamps, N.

Afiliação

Azoulai D; Department of Urology, Cochin Hospital, University of Paris, Paris, France. Electronic address: David.azoulai@aphp.fr.
Boustany J; Department of Urology, Cochin Hospital, University of Paris, Paris, France.
Peyromaure M; Department of Urology, Cochin Hospital, University of Paris, Paris, France.
Abou Chakra M; Department of Urology, Cochin Hospital, University of Paris, Paris, France.
Duquesne I; Department of Urology, Cochin Hospital, University of Paris, Paris, France.
Barry Delongchamps N; Department of Urology, Cochin Hospital, University of Paris, Paris, France.

Prog Urol ; 32(16): 1469-1475, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35941010

Assuntos

Antígeno Prostático Específico; Neoplasias da Próstata; Masculino; Humanos; Estudos Retrospectivos; Estadiamento de Neoplasias; Neoplasias da Próstata/cirurgia; Neoplasias da Próstata/patologia; Prostatectomia/métodos

Palavras-chave

Biopsie; Biopsy; Cancer de la prostate; Consensus; Critères d'éligibilité; Eligibility criteria; Focal therapy; Patient selection; Prostate cancer; Sélection des patients; Thérapie focale

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google